series-c-plus
Stage
2016
Founded
2
Investors
About
SparingVision is a clinical-stage genomic medicine company focused on developing innovative gene therapies to treat inherited retinal diseases and other ocular conditions.
Explore SparingVision's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.